Altimmune (ALT1) Ratios
Altimmune Ratios
MX:ALT1's free cash flow for Q2 2026 was $-24.25M. For the 2026 fiscal year, MX:ALT1's free cash flow was decreased by $-32.00K and operating cash flow was $-24.22M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 18.55 | 13.11 | 17.26 | 11.31 | 11.17 |
| Quick Ratio | 18.55 | 13.11 | 17.26 | 11.31 | 11.17 |
| Cash Ratio | 2.92 | 3.53 | 11.13 | 6.51 | 10.41 |
| Solvency Ratio | -1.60 | -6.00 | -5.32 | -3.89 | -4.89 |
| Operating Cash Flow Ratio | -4.50 | -7.63 | -6.24 | -3.67 | -4.28 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 223.16M | $ 121.46M | $ 193.09M | $ 171.18M | $ 184.40M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.01 | 0.00 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.16 | 0.01 | 0.00 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.14 | 0.01 | 0.00 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.24 | 1.13 | 1.09 | 1.12 | 1.10 |
| Debt Service Coverage Ratio | -52.78 | -10534.67 | -2512.43 | -10526.50 | -19306.80 |
| Interest Coverage Ratio | -57.76 | -11463.56 | -2740.83 | -10967.50 | -19382.80 |
| Debt to Market Cap | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.42 | 0.02 | 0.01 | 0.02 | 0.04 |
| Net Debt to EBITDA | 0.09 | 0.37 | 1.53 | 1.30 | 1.96 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -212531.71% | -475250.00% | -20753.99% | 124855.88% | -2201.47% |
| EBITDA Margin | -212258.54% | -474060.00% | -20642.02% | 124130.88% | -2188.98% |
| Operating Profit Margin | -230460.98% | -515860.00% | -22518.54% | 129029.41% | -2197.60% |
| Pretax Profit Margin | -216521.95% | -475295.00% | -20762.21% | 124867.65% | -2201.59% |
| Net Profit Margin | -214860.98% | -475295.00% | -20762.21% | 124577.94% | -2201.59% |
| Continuous Operations Profit Margin | -214860.98% | -475295.00% | -20762.21% | 124577.94% | -2201.59% |
| Net Income Per EBT | 99.23% | 100.00% | 100.00% | 99.77% | 100.00% |
| EBT Per EBIT | 93.95% | 92.14% | 92.20% | 96.77% | 100.18% |
| Return on Assets (ROA) | -31.47% | -68.24% | -41.99% | -40.94% | -44.36% |
| Return on Equity (ROE) | -39.17% | -76.97% | -45.57% | -45.72% | -48.76% |
| Return on Capital Employed (ROCE) | -35.67% | -80.08% | -48.33% | -46.21% | -48.31% |
| Return on Invested Capital (ROIC) | -35.36% | -79.91% | -48.21% | -45.99% | -48.22% |
| Return on Tangible Assets | -31.47% | -68.24% | -41.99% | -43.55% | -47.03% |
| Earnings Yield | -27.70% | -18.57% | -14.77% | -10.97% | -25.67% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.02 | 0.01 | 0.09 | -0.03 | 0.76 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.13 | 0.05 | 0.65 | -0.06 | 3.05 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | -0.00 | 0.02 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | -0.00 | 0.02 |
| Cash Conversion Cycle | 15463.54 | 56885.25 | 4158.09 | -13639.19 | 483.27 |
| Days of Sales Outstanding | 15463.54 | 56885.25 | 4158.09 | -13639.19 | 483.27 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 15463.54 | 56885.25 | 4158.09 | -13639.19 | 483.27 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.77 | -1.12 | -1.42 | -1.33 | -1.90 |
| Free Cash Flow Per Share | -0.77 | -1.12 | -1.42 | -1.34 | -2.19 |
| Dividend Paid and CapEx Coverage Ratio | -6139.55 | 0.00 | -1612.98 | -496.71 | -6.35 |
| Capital Expenditure Coverage Ratio | -6139.55 | 0.00 | -1612.98 | -496.71 | -6.35 |
| Operating Cash Flow Coverage Ratio | -1.89 | -47.50 | -112.98 | -55.68 | -50.97 |
| Operating Cash Flow to Sales Ratio | -1647.20 | -3992.40 | -177.96 | 920.38 | -17.74 |
| Free Cash Flow Yield | -21.24% | -15.60% | -12.66% | -8.12% | -23.95% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.61 | -5.38 | -6.77 | -9.11 | -3.89 |
| Price-to-Sales (P/S) Ratio | 7757.46 | 25596.73 | 1406.17 | -11352.04 | 85.75 |
| Price-to-Book (P/B) Ratio | 1.41 | 4.14 | 3.09 | 4.17 | 1.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.71 | -6.41 | -7.90 | -12.31 | -4.18 |
| Price-to-Operating Cash Flow Ratio | -4.71 | -6.41 | -7.90 | -12.33 | -4.83 |
| Price-to-Earnings Growth (PEG) Ratio | 0.14 | 0.28 | 0.82 | 0.40 | -0.17 |
| Enterprise Value Multiple | -3.56 | -5.03 | -5.28 | -7.84 | -1.96 |
| Enterprise Value | 309.98M | 476.69M | 464.58M | 661.97M | 189.39M |
| EV to EBITDA | -3.56 | -5.03 | -5.28 | -7.84 | -1.96 |
| EV to Sales | 7560.58 | 23834.48 | 1090.57 | -9734.79 | 42.95 |
| EV to Free Cash Flow | -4.59 | -5.97 | -6.12 | -10.56 | -2.09 |
| EV to Operating Cash Flow | -4.59 | -5.97 | -6.13 | -10.58 | -2.42 |
| Tangible Book Value Per Share | 2.55 | 1.74 | 3.65 | 3.68 | 4.52 |
| Shareholders’ Equity Per Share | 2.55 | 1.74 | 3.65 | 3.95 | 4.82 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.01 | -0.00 | 0.11 |
| Net Income Per Share | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 |
| Tax Burden | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 1620.29 | 4111.30 | 154.46 | -1037.32 | 16.90 |
| SG&A to Revenue | 685.32 | 1048.30 | 42.58 | -251.97 | 3.50 |
| Stock-Based Compensation to Revenue | 392.10 | 719.65 | 24.98 | -119.13 | 1.25 |
| Income Quality | 0.77 | 0.84 | 0.86 | 0.74 | 0.81 |
Currency in USD
